BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8988697)

  • 1. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
    Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in neural tube defects 1980-1989.
    Bower C; Raymond M; Lumley J; Bury G
    Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
    Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
    Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
    Cuckle HS; Wald NJ; Cuckle PM
    Prenat Diagn; 1989 Jun; 9(6):393-400. PubMed ID: 2668917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
    Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
    Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland.
    Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES
    Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of serum-alpha-fetoprotein screening for fetal neural-tube defects.
    Clarke M
    Lancet; 1977 May; 1(8021):1098-9. PubMed ID: 68191
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limitation of referral level fetal ultrasound examination in the detection of spina bifida in Western Australia, 1990-1991.
    Walpole IR; Phillips J; Pemberton PJ; Bower C; Goldblatt J
    Med J Aust; 1993 Oct; 159(7):441-4. PubMed ID: 7692226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for neural tube defects.
    Cuckle HS
    Ciba Found Symp; 1994; 181():253-66; discussion 266-9. PubMed ID: 7516277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994.
    Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH
    MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural tube defect diagnosis and outcomes at a tertiary South African hospital with intensive case ascertainment.
    Krzesinski EI; Geerts L; Urban MF
    S Afr Med J; 2019 Aug; 109(9):698-703. PubMed ID: 31635597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
    Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP
    AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe.
    Boyd PA; Wellesley DG; De Walle HE; Tenconi R; Garcia-Minaur S; Zandwijken GR; Stoll C; Clementi M
    J Med Screen; 2000; 7(4):169-74. PubMed ID: 11202581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects.
    Douglas Wilson R; Van Mieghem T; Langlois S; Church P
    J Obstet Gynaecol Can; 2021 Jan; 43(1):124-139.e8. PubMed ID: 33212246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
    Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
    Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.